secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001437749-25-020652
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Allarity shareholders reject equity plan increase and officer exculpation
-------------------------------------------------------------------------

- Thomas H. Jensen re-elected as Class III director with 1,673,698 for, 265,465 withheld.
- Ratification of Wolf & Company as auditor passed with 6,706,148 votes for.
- Proposal to increase 2021 Plan shares from 717,941 to 3,415,068 failed (928,978 for vs 932,866 against).
- Amendment to limit officer liability (Officer Exculpation) also did not pass (1,359,331 for vs 563,585 against).
- Adjournment proposal approved 4,976,159 for, 1,924,694 against; quorum was 41% of outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000143774925020652/0001437749-25-020652-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000143774925020652/allr20250617_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-020652

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer